https://www.selleckchem.com/pr....oducts/ertugliflozin
mographics, patient characteristics, disease history, complications, and concomitant medications. Data will be transferred to the study database by the app upon completion of each questionnaire. Statistical analyses of primary and secondary endpoints will be exploratory and descriptive. Enrollment began in June 2020. The estimated study completion date is December 31, 2020, and the planned sample size is 300 patients. The DePRO study uses completely digital data collection, including authentication of eligible patients and complet
Like
Comment
Share
